| Literature DB >> 28945395 |
Abstract
Diagnosing disease at the molecular level rapidly and with a high level of sensitivity and specificity is a critical capability for modern medicine. Rapid detection of small numbers of biomarkers of early disease in complex, heterogeneous clinical specimens represents a Holy Grail that will have a significant impact on human health.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28945395 DOI： 10.1021/acs.accounts.6b00497
Source DB: PubMed Journal: Acc Chem Res ISSN： 0001-4842 Impact factor: 22.384